Image-guided cryoablation for the treatment of painful musculoskeletal metastatic disease: a single-center experience
Autor: | J. David Prologo, David Corn, Matthew Passalacqua, Nathan Bohnert, Indravadan Patel |
---|---|
Rok vydání: | 2014 |
Předmět: |
Adult
Male medicine.medical_specialty Percutaneous Visual analogue scale medicine.medical_treatment Bone Neoplasms Cryosurgery medicine Humans Radiology Nuclear Medicine and imaging Aged Pain Measurement Retrospective Studies Aged 80 and over business.industry Medical record Palliative Care Cryoablation Middle Aged Institutional review board medicine.disease Arthralgia Primary tumor Surgery Radiation therapy Treatment Outcome Surgery Computer-Assisted Orthopedic surgery Female Radiology Tomography X-Ray Computed business |
Zdroj: | Skeletal Radiology. 43:1551-1559 |
ISSN: | 1432-2161 0364-2348 |
DOI: | 10.1007/s00256-014-1939-x |
Popis: | The role of image-guided thermal ablation techniques for the nonoperative local management of painful osseous metastatic disease has expanded during recent years, and several advantages of cryoablation in this setting have emerged. The purpose of this study is to retrospectively evaluate and report a single-center experience of CT-guided percutaneous cryoablation in the setting of painful musculoskeletal metastatic disease. This study was approved by the institutional review board and is compliant with the Health Insurance Portability and Accountability Act. Electronic medical records of all patients who underwent percutaneous image-guided palliative cryoablation at our institution were reviewed (n = 61). An intent-to-treat analysis was performed. Records were reviewed for demographic data and anatomical data, primary tumor type, procedure details, and outcome—including change in analgesic requirements (expressed as morphine equivalent dosages), pain scores (utilizing the clinically implemented visual analog scale), subsequent therapies (including radiation and/or surgery), and complications during the 24 h following the procedure and at 3 months. Patients were excluded (n = 7) if data were not retrospectively identifiable at the defined time points. Fifty-four tumors were ablated in 50 patients. There were statistically significant decreases in the median VAS score and narcotic usage at both 24 h and 3 months (p |
Databáze: | OpenAIRE |
Externí odkaz: |